No need to wear glasses while reading, ‘PresVu’ eye drops get DCGI approval

Newsdesk:
Mumbai-based Entode Pharmaceuticals has developed Preswoo Eye Drop for the treatment of presbyopia.  It is a condition that affects between 1.09 billion and 1.80 billion people worldwide.
 With aging, a person faces the problem of presbyopia, which is natural.  A person suffering from this problem has trouble seeing objects held nearby.  This problem mostly affects people over 40 years of age.
 Following the recommendation of the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO), ENTOD Pharmaceuticals has received final approval for the product from the Drug Controller General of India (DCGI).